• Immunization:
    • IM 0.5mL *1 at 2 months, 4 months and 6 months for 3 total doses

Injection: Each 0.5ml contains:

  • diphtheria toxoid 25 Lf
  • tetanus toxoid 10 Lf
  • inactivated pertussis toxin (PT) 25mcg
  • filamentous hemagglutinin (FHA) 25mcg
  • pertactin 8mcg
  • hepatitis B surface antigen (HBsAg) 10mcg
  • type 1 poliovirus 40 D-antigen units
  • type 2 poliovirus8 D-antigen units
  • type 3 poliovirus 32 D-antigen units)
  • Administration:
    • < 1 years: Anterolateral thigh
    • >1 years: Deltoid muscle

Vaccine

It induces antibody formation

  • Irritability
  • Drowsiness
  • Injection site reaction
  • Fever
  • Anorexia
  • Hypersensitivity to any component (including yeast, neomycin, polymyxin B)
  • Encephalopathy within 7 days after prior pertussis vaccine use
  • Belimumab
  • Interferon gamma 1b

                          Drug Status

Availability Prescription only
Pregnancy Only indicated in peds
Breastfeeding Only indicated in peds
Schedule Not controlled
BRAND NAME STRENGTH FORMULATION PACK SIZE MANUFACTURER DISTRIBUTOR
Column 1 Value Column 2 Value Column 3 Value Column 4 Value Column 5 Value Column 6 Value